Literature DB >> 2906547

Propranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled study.

M S Kramer1, R A Gorkin, C DiJohnson, P Sheves.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906547     DOI: 10.1016/0006-3223(88)90260-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  6 in total

1.  The Hillside Akathisia Scale: a reliability comparison of the English and German versions.

Authors:  W W Fleischhacker; C H Miller; P Schett; C Barnas; H Ehrmann
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

Review 3.  Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Authors:  M R Caligiuri; D V Jeste; J P Lacro
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 4.  Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia.

Authors:  A R Lima; J Bacalcthuk; T R E Barnes; K Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

5.  The Assessment and Treatment of Antipsychotic-Induced Akathisia.

Authors:  Tamara Pringsheim; David Gardner; Donald Addington; Davide Martino; Francesca Morgante; Lucia Ricciardi; Norman Poole; Gary Remington; Mark Edwards; Alan Carson; Thomas R E Barnes
Journal:  Can J Psychiatry       Date:  2018-04-23       Impact factor: 4.356

6.  Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study.

Authors:  Masahiro Takeshima; Hiroyasu Ishikawa; Takashi Kanbayashi; Tetsuo Shimizu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-22       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.